Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in GTBP — GT Biopharma, Inc.

CIK 1214717 BOSTON, MA
Back to GTBP Full portfolio

Position in GTBP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$130,725
+$10,586 QoQ
Shares Held
10,672
-9.4% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 57 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. GTBP ranks #428 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in GTBP

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $130,725 266,788
2026-03-31 $120,139 294,459
2025-12-31 $15,116 19,258
2025-09-30 $14,067 23,966
2025-06-30 $85,335 23,837
2025-03-31 $49,634 23,086
2024-12-31 $45,441 14,899
2024-09-30 $34,728 15,041
2024-06-30 $31,650 11,184
2024-03-31 $49,545 11,184
2023-12-31 $86,015 337,315
2023-09-30 $81,292 337,315
2023-06-30 $69,714 223,444
2023-03-31 $122,894 223,444
2022-12-31 $197,971 223,444
2022-09-30 $394,078 223,908
2022-06-30 $799,238 267,304
2022-03-31 $1,043,752 362,414
2021-12-31 $1,183,241 387,948
2021-09-30 $2,859,640 424,279
2021-06-30 $5,372,392 346,606
2021-03-31 $891,853 130,388